AACR D3 Offered a Peek Into the Cancer Drug Pipeline, Innovative AI Tools, and More
We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference,...
Tag: Artificial intelligence
We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference,...
During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO,...
Can AI agents do cancer research? Many AI-centric research teams currently believe that with the right training, AI agents...
Researchers are building AI agents to assess how patients could respond to therapy and aid doctors in making cancer...
The latest edition of our "From the Bench" series examines creative research approaches presented at the AACR Annual Meeting...
An AACR Patient Advocate Forum assembled a panel of experts to discuss how AI tools can help advance cancer...
The spring 2026 issue of Cancer Today included articles about using AI chatbots, cancer survivor—and “Survivor” winner—Ethan Zohn, and...
Keith Flaherty, William Hait, Nina Bhardwaj, Dana Pe’er, and Marcia Cruz-Correa forecast what advances to expect in cancer research...
Researchers highlighted AI's potential to enhance clinical cancer care, including to improve diagnosis, guide precision medicine, and more.
The AACR hosted a Virtual Patient Advocate Forum in July 2025 on technology’s role in cancer care.